DRUG DISCOVERY & R&D · COMPARISON

Insilico Medicine vs Exscientia AI

Side-by-side comparison across 10 capabilities + AI Due Diligence. 12 total vendors in this category.

QUICK VERDICT
Insilico Medicine wins on
Biomarker discovery, Clinical trial design optimization, Clinical-stage pipeline
Exscientia AI wins on
Overall capability coverage (71%)
Shared strength
ADMET prediction, AI target identification, Generative molecule design
AI DUE DILIGENCE

Side-by-side trust profiles

40/50
AI DUE DILIGENCE

Insilico Medicine

AI-NativeLow risk
12345
1Classification
10/10
2Model Independence
9/10
3Learning Loop
8/10
4Data Sovereignty
3/10
5Dependency
10/10
40/50
AI DUE DILIGENCE

Exscientia AI

AI-NativeLow risk
12345
1Classification
10/10
2Model Independence
9/10
3Learning Loop
8/10
4Data Sovereignty
3/10
5Dependency
10/10
CAPABILITY MATRIX

Top 10 capabilities scored

Full = production-grade · Partial = emerging/limited · None = not offered

CapabilityInsilico MedicineExscientia AI
ADMET prediction
AI target identification
Generative molecule design
Lead optimization
Protein structure prediction
Virtual screening at scale
Biomarker discovery
½
Clinical trial design optimization
½
Clinical-stage pipeline
½
Automated lab integration
½
½
OVERALL COVERAGE88%71%
WHEN TO PICK EACH

Same category. Different trade-offs.

Pick Insilico Medicine if…

  • You need: Biomarker discovery, Clinical trial design optimization, Clinical-stage pipeline
  • AI-native architecture matters for your risk review
  • Low third-party model dependency is a requirement
  • Overall capability breadth (88%) is the primary driver

Pick Exscientia AI if…

  • AI-native architecture matters for your risk review
  • Low third-party model dependency is a requirement
ALSO CONSIDER

Other Drug Discovery & R&D vendors

Recursion Pharmaceuticals
71% COVERAGE
BenevolentAI
63% COVERAGE
Relay Therapeutics
58% COVERAGE
GO DEEPER
See all 12 Drug Discovery & R&D vendors · weight capabilities · export a shareable report.
Sign up free

Frequently asked

Insilico Medicine has higher overall capability coverage (88% vs 71%) for Drug Discovery & R&D. The right choice depends on which specific capabilities your team needs — see the full matrix above.